Literature DB >> 6985362

Dimeric, trimeric and tetrameric complexes of immunoglobulin G fix complement.

J K Wright, J Tschopp, J C Jaton, J Engel.   

Abstract

The binding of pure dimers, trimers and tetramers of randomly cross-linked non-immune rabbit immunoglobulin G to the first component and subcomponent of the complement system, C1 and C1q respectively, was studied. These oligomers possessed open linear structures. All three oligomers fixed complement with decreasing affinity in the order: tetramer, trimer, dimer. Complement fixation by dimeric immunoglobulin exhibited the strongest concentration-dependence. No clear distinction between a non-co-operative and a co-operative binding mechanism could be achieved, although the steepness of the complement-fixation curves for dimers and trimers was better reflected by the co-operative mechanism. Intrinsic binding constants were about 10(6)M-1 for dimers, 10(7)M-1 for trimers and 3 X 10(9)M-1 for tetramers, assuming non-co-operative binding. The data are consistent with a maximum valency of complement component C1 for immunoglobulin G protomers in the range 6-18. The binding of dimers to purified complement subcomponent C1q was demonstrated by sedimentation-velocity ultracentrifugation. Mild reduction of the complexes by dithioerythritol caused the immunoglobulin to revert to the monomeric state (S20,w = 6.2-6.5S) with concomitant loss of complement-fixing ability.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6985362      PMCID: PMC1162461          DOI: 10.1042/bj1870775

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Antigen-induced conformational changes in antibodies and their Fab fragments studied by circular polarization of fluorescence.

Authors:  J Schlessinger; I Z Steinberg; D Givol; J Hochman; I Pecht
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

2.  Selective reduction and proteolysis in the hinge region of liganded and unliganded antibodies: identical kinetics suggest lack of major conformational change in the hinge region.

Authors:  J K Wright; J Engel; J C Jaton
Journal:  Eur J Immunol       Date:  1978-05       Impact factor: 5.532

Review 3.  The effect of antigen on antibodies: recent studies.

Authors:  H Metzger
Journal:  Contemp Top Mol Immunol       Date:  1978

4.  Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice.

Authors:  J D McGhee; P H von Hippel
Journal:  J Mol Biol       Date:  1974-06-25       Impact factor: 5.469

5.  A simple method for the isolation of the subcomponents of the first component of complement by affinity chromatography.

Authors:  S N Assimeh; D H Bing; R H Painter
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

6.  The fixation of complement and the activated first component (C1) of complement by complexes formed between antibody and divalent hapten.

Authors:  N E Hyslop; R R Dourmashkin; N M Green; R R Porter
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

7.  Reduced immunoglobulin G activates complement system with decreased cooperativity.

Authors:  J K Wright
Journal:  Biochem Biophys Res Commun       Date:  1978-08-29       Impact factor: 3.575

8.  Crystal structure of the human Fab fragment Kol and its comparison with the intact Kol molecule.

Authors:  M Matsushima; M Marquart; T A Jones; P M Colman; K Bartels; R Huber
Journal:  J Mol Biol       Date:  1978-06-05       Impact factor: 5.469

9.  Complement fixation by model immune complexes free in solution and bound onto cell surfaces.

Authors:  D M Segal; R L Guyer; P H Plotz
Journal:  Biochemistry       Date:  1979-05-01       Impact factor: 3.162

10.  Preparation and characterization of chemically defined oligomers of rabbit immunoglobulin G molecules for the complement binding studies.

Authors:  J K Wright; J Tschopp; J C Jaton
Journal:  Biochem J       Date:  1980-06-01       Impact factor: 3.857

View more
  12 in total

1.  Comparison of the role of tyrosine residues in human IgG and rabbit IgG in binding of complement subcomponent C1q.

Authors:  M N McCall; S B Easterbrook-Smith
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

2.  Quantitative analysis of the interaction between immune complex and C1q complement subcomponent. The role of interdomain interactions in rabbit IgG in binding of C1q to immune precipitates.

Authors:  F Vonderviszt; J Török; S Lakatos; F Kilár; P Závodszky
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

3.  TUNABLE COMPLEMENT ACTIVATION BY PARTICLES WITH VARIABLE SIZE AND Fc DENSITY.

Authors:  Patricia M Pacheco; Benjamin LE; David White; Todd Sulchek
Journal:  Nano Life       Date:  2013-06

4.  Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system.

Authors:  H Jiang; T F Lint; H Gewurz
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

5.  Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.

Authors:  G Doekes; L A Vanes; M R Daha
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

6.  C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.

Authors:  G Doekes; L A van Es; M R Daha
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

7.  Formation of complement subcomponent C1q-immunoglobulin G complex. Thermodynamic and chemical-modification studies.

Authors:  E J Emanuel; A D Brampton; D R Burton; R A Dwek
Journal:  Biochem J       Date:  1982-08-01       Impact factor: 3.857

8.  Preparation and characterization of chemically defined oligomers of rabbit immunoglobulin G molecules for the complement binding studies.

Authors:  J K Wright; J Tschopp; J C Jaton
Journal:  Biochem J       Date:  1980-06-01       Impact factor: 3.857

9.  Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41.

Authors:  C F Ebenbichler; N M Thielens; R Vornhagen; P Marschang; G J Arlaud; M P Dierich
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

10.  Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity.

Authors:  P Schneider; N Holler; J L Bodmer; M Hahne; K Frei; A Fontana; J Tschopp
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.